Therapeutic Efficacy of an Angiotensin II Receptor Antagonist in Patients with Nonalcoholic Steathepatitis
Phase 4
- Conditions
- onalcoholic steatohepatitis
- Registration Number
- JPRN-C000000202
- Lead Sponsor
- Gunma Liver Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Allergy to Angiotensin II receptor Antagonist(ARB) complication with liver diseases due to other causes secondary NASH medication history of ARB or ACE inhibitors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method transaminase
- Secondary Outcome Measures
Name Time Method insulin resistance liver histology